GlobalSpace Technologies Reports 83% Revenue Growth In Q4 FY26

GlobalSpace Technologies Limited reported strong consolidated revenue growth in Q4 FY26, helped by improved performance across its healthcare and technology businesses. Revenue from operations rose 83% year-on-year to ₹16.0 crore in the January-March 2026 quarter, compared with ₹8.8 crore in the corresponding quarter last year. The company reported a consolidated net profit of ₹2.5 crore during the quarter against a net loss of ₹0.2 crore a year ago.

Sequential And Annual Growth

On a sequential basis, revenue declined 3.5% from ₹16.6 crore reported in Q3 FY26. Net profit, however, increased sharply from ₹0.4 crore in the previous quarter. Profit before tax stood at ₹0.5 crore in Q4 FY26 against ₹0.9 crore in Q3 FY26, while the company had reported a loss before tax in Q4 FY25. Total expenses during the quarter increased to ₹15.9 crore from ₹8.9 crore in the year-ago period due to higher employee costs and operational spending. Deferred tax gains of ₹2.1 crore also supported profitability during the quarter.

What Drove The Numbers

The filing showed that Innopharm Healthcare Private Limited contributed ₹5.6 crore to quarterly revenue, compared with ₹3.7 crore in the corresponding quarter last year. The company’s standalone business generated ₹10.5 crore in quarterly revenue. Employee benefit expenses increased significantly to ₹4.3 crore in Q4 FY26 from ₹0.9 crore a year earlier, reflecting expansion in operations. Basic and diluted earnings per share stood at ₹0.68 for the quarter, compared with a negative EPS of ₹4.14 in Q4 FY25.

Full-Year Performance

For FY26, consolidated revenue from operations rose 20% to ₹51.5 crore from ₹43.0 crore in FY25. The company posted a net profit of ₹2.9 crore for the full year against a net loss of ₹2.0 crore in FY25. Total comprehensive income stood at ₹2.7 crore for FY26. The company also approved the appointment of Tania Mazumdar as Chief Executive Officer for a three-year term and granted 4.9 lakh employee stock options during the board meeting.

Disclaimer: This report is based on audited financial results filed by the company and does not constitute investment advice.